fda novavax news - Search News

Novavax Gets FDA Approval To Resume Testing 2 Vaccines

Novavax Gets FDA Approval To Resume Testing Two Vaccines After Clinical Hold

The company explained that the U.S. Food and Drug Administration (FDA) removed its clinical hold on the studies, and will allow it "to begin enrolling the planned Phase 3 trial following the determination that Novavax satisfactorily addressed all clinical ...

Reuters on MSN · 2d

US FDA lifts clinical hold on Novavax's combo COVID-flu shot

The U.S. Food and Drug Administration has lifted its clinical hold on a late-stage trial of Novavax's COVID-influenza and its standalone flu vaccines after a safety concern was found to be unrelated to the combination shot,

Yahoo Finance · 2d

FDA clears Novavax to resume trials of Covid-19 and flu combo vaccine

Novavax has received the green light from the US Food and Drug Administration (FDA) to resume clinical trials for its Covid-19 and influenza combination vaccine (CIC) and standalone influenza vaccines after a month-long clinical hold. The FDA initially ...

Novavax Stock is Slipping

Benzinga.com · 1d

Novavax Lowers 2024 Forecast Despite Q3 Revenue Beat, Stock Falls

Novavax reports Q3 2024 sales of $84.5 million, beating estimates, with a net loss of $121 million. EPS improves, FDA approves new vaccine, and revenue guidance is lowered.

Hosted on MSN · 1d

Novavax cuts 2024 revenue forecast again on lower COVID vaccine sales

Novavax cut its annual revenue forecast on Tuesday, citing lower-than-expected sales of its COVID-19 vaccine, ahead of handing over the rights to sell the shot to French drugmaker Sanofi. Shares of the U.

Investopedia on MSN · 1d

Novavax Stock is Slipping After the Vaccine Maker Cut its Outlook Again

Key Takeaways Novavax shares fell after the company dropped its full-year revenue guidance with its third-quarter results.The company has cut its guidance multiple times this year, and the new range is below the analyst consensus.

Becker's Hospital Review1d

FDA lifts clinical hold on combined COVID-19-influenza vaccine trials

Novavax received clearance from the FDA to move forward with phase 3 clinical trials for its COVID-19-influenza combination (CIC) and standalone influenza vaccines. The FDA lifted a clinical ...

Novavax Gains Competitive Edge with FDA Clearance and Strategic Collaborations, Earning Buy Rating

H.C. Wainwright analyst Vernon Bernardino reiterated a Buy rating on Novavax (NVAX – Research Report) today and set a price target of ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results

Novavax Gets FDA Approval To Resume Testing 2 Vaccines

Novavax Stock is Slipping

Trending now